Erics Lander News Today

Housing Secretary Marcia Fudge says she will resign her position next week, alerting her staff in an email she wrote Monday.

<p>Over the past 15 years, researchers have identified hundreds of regions in the human genome associated with heart attack risk. However, researchers lack efficient ways to explore how these genetic variants are molecularly connected to cardiovascular disease, limiting efforts to develop therapeutics. To streamline analysis of hundreds of genetic variants associated with coronary artery disease (CAD), a team of researchers led by investigators from <a href="https://brighamandwomen...

An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.

Scientists doing “gain-of-function” research said that heightened fears of lab leaks are stalling studies that could thwart the next pandemic virus.

Two years after launching what officials hailed as a five year flagship project for hunting viruses among wildlife to prevent human pandemics, the US Agency for International Development is shuttering the enterprise. David Willman reports A flagship project for the controversial practice of hunting viruses among wildlife in South East Asia, Africa, and Latin America to prevent human outbreaks and pandemics is being quietly dropped by the United States Agency for International Development (USAID)...

Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. The firm currently has $36.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $24.00. Several other research firms have also recently weighed […]

Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. Mizuho currently has $36.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $24.00. VSTM has been the topic of a number of […]

Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been assigned an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the stock in the last […]

StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Cantor Fitzgerald restated an overweight rating on shares of Verastem in a research note on […]

StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other reports. HC Wainwright decreased their price objective on Verastem from $3.00 to $2.00 in a report […]